Related Experiment Videos
Xenobiotic metabolism in brain
V Ravindranath1, S Bhamre, S V Bhagwat
1Department of Neurochemistry, National Institute of Mental Health and Neuroscience, Bangalore, India.
Toxicology Letters
|December 1, 1995
Summary
The brain possesses drug-metabolizing enzymes like cytochromes P-450 (P450) and flavin-containing monooxygenase (FMO). These enzymes metabolize environmental toxins and psychoactive drugs, influencing neurodegenerative disease research.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Emerging hypotheses link environmental toxins to neurodegenerative disorders.
- Understanding xenobiotic metabolism in the brain is crucial for neuroprotection.
- Brain enzymes may modulate drug action and contribute to neuronal health.
Purpose of the Study:
- To investigate the presence and function of xenobiotic metabolizing enzymes in the brain.
- To explore the role of these enzymes in the metabolism of drugs and toxins.
- To examine the distribution and characteristics of brain-specific enzymes.
Main Methods:
- Detection of cytochromes P-450 (P450) and flavin-containing monooxygenase (FMO) in rodent and human brain tissue.
- Analysis of brain microsomal and mitochondrial enzyme systems.
- Immunocytochemical studies to determine enzyme distribution and localization.
Main Results:
- P450 and FMO enzymes are present in the brain, metabolizing various xenobiotics and psychoactive drugs.
- Regional heterogeneity in P450 distribution was observed.
- These enzymes are predominantly localized in neuronal cells, with some distinct differences from liver/lung counterparts.
Conclusions:
- The brain possesses significant xenobiotic metabolizing capabilities, particularly for lipophilic compounds entering via bloodstream.
- Brain P450 and FMO play a role in modulating drug action and potentially in neurodegenerative processes.
- Further research into brain xenobiotic metabolism is warranted for understanding neurological diseases.